## Image Findings * **Multiple cutaneous neurofibromas:** Numerous skin-colored to pinkish, soft, dome-shaped to pedunculated papules and nodules are visible on the scalp, periauricular region, and neck, particularly prominent in the left image. * **Freckling:** Diffuse hyperpigmented macules (ephelides-like freckling) are present on the facial skin and neck. * **Confetti-like hypopigmentation:** Numerous small, punctate, hypopigmented macules are clearly visible on the neck and lower face in the right image. ## Diagnosis **Key Point:** The combination of multiple cutaneous neurofibromas, diffuse freckling, and confetti-like hypopigmentation is pathognomonic for **Neurofibromatosis Type 1 (NF1)**. Neurofibromatosis Type 1 is an autosomal dominant neurocutaneous disorder caused by a mutation in the *NF1* gene on chromosome 17. It is characterized by a wide range of clinical manifestations, primarily affecting the skin, nervous system, and bones. The visible cutaneous neurofibromas are benign peripheral nerve sheath tumors. The freckling, especially in non-sun-exposed areas (like axilla/groin, known as Crowe's sign), and the distinctive confetti-like hypopigmentation are highly characteristic diagnostic criteria. ## Differential Diagnosis | Feature | Neurofibromatosis Type 1 (NF1) | Tuberous Sclerosis (TSC) | Sturge-Weber Syndrome (SWS) | | :------------------ | :------------------------------------------------------------ | :----------------------------------------------------------- | :------------------------------------------------------------ | | **Skin Lesions** | Cutaneous neurofibromas, café-au-lait macules, freckling (Crowe's sign), confetti-like hypopigmentation | Facial angiofibromas, shagreen patches, ash-leaf spots, periungual fibromas | Port-wine stain (nevus flammeus) in trigeminal distribution | | **Neurological** | Optic pathway gliomas, plexiform neurofibromas, learning disabilities | Cortical tubers, subependymal nodules, giant cell astrocytomas, epilepsy, intellectual disability | Leptomeningeal angioma, seizures, intellectual disability | | **Other Features** | Lisch nodules (iris hamartomas), bone lesions, vasculopathy | Renal angiomyolipomas, cardiac rhabdomyomas, retinal hamartomas | Ocular (glaucoma), vascular malformations | ## Clinical Relevance **Clinical Pearl:** NF1 is a multisystem disorder. Patients require regular screening for complications such as optic pathway gliomas, hypertension, scoliosis, and malignant transformation of plexiform neurofibromas. ## High-Yield for NEET PG **High-Yield:** The diagnostic criteria for NF1 include two or more of the following: * Six or more café-au-lait macules (prepubertal > 0.5 cm, postpubertal > 1.5 cm) * Two or more neurofibromas of any type or one plexiform neurofibroma * Axillary or inguinal freckling (Crowe's sign) * Optic pathway glioma * Two or more Lisch nodules (iris hamartomas) * A distinctive osseous lesion (e.g., sphenoid wing dysplasia, pseudoarthrosis) * A first-degree relative with NF1. **Key Point:** Confetti-like hypopigmentation, though not part of the official NIH diagnostic criteria, is a highly specific and often early sign of NF1. ## Common Traps **Warning:** Differentiating NF1 from other phakomatoses like Tuberous Sclerosis is crucial. While both have skin lesions and neurological involvement, the specific morphology and distribution of the lesions (e.g., neurofibromas vs. angiofibromas, confetti-like hypopigmentation vs. ash-leaf spots) are distinct. ## Reference [cite:Robbins Basic Pathology, 10th ed, Ch 27, p. 869-870]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.